Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients

The histamine-1 receptor antagonist azelastine was recently found to impact SARS-CoV-2 viral kinetics in a Phase 2 clinical trial (CARVIN). Thus, we investigated the relationship between intranasal azelastine administrations and viral load, as well as symptom severity in COVID-19 patients and analyz...

Full description

Saved in:
Bibliographic Details
Main Authors: Christiane Dings (Author), Peter Meiser (Author), Frank Holzer (Author), Michael Flegel (Author), Dominik Selzer (Author), Eszter Nagy (Author), Ralph Mösges (Author), Jens Peter Klussmann (Author), Thorsten Lehr (Author)
Format: Book
Published: MDPI AG, 2022-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available